Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION (Tables)

v3.22.1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
   
Year ended December 31,
   
2021
 
2020
 
2019
             
Expected term, in years
  4.40   6.25   6.25
Expected volatility
  64%   65%  
65% - 70%
Risk-Free interest rate
 
0.48% - 1.01%
 
0.46% - 1.74%
 
1.77% - 2.65%
Expected dividend yield
  0%   0%   0%
Summary of Share-Based Compensation Arrangements by Share-based Payment Award
   
Number of options
   
Weighted-average exercise price
   
Weighted- average remaining contractual term
(in years)
   
Aggregate intrinsic value
 
                         
Outstanding at January 1, 2021
    8,470,761    
$
0.68       7.92    
$
43,598  
                                 
Granted
    10,080,000    
$
8.56                  
Exercised
    (1,918,100
)
 
$
0.50            
$
2,363  
Forfeited
    (395,313
)
 
$
2.75                  
Expired
    (2
)
 
$
1.14                  
                                 
Outstanding at December 31, 2021
    16,237,346    
$
5.55       6.95    
$
12,905  
                                 
Exercisable at December 31, 2021
    7,897,642    
$
5.47       6.60    
$
6,902  
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]

 

   
Number of
shares
   
Weighted average grant date fair value per share
 
             
Unvested as of December 31, 2020
    -    
$
-  
Granted
    6,361,724    
$
9.26  
Vested
   
(2,413,667
)
 
$
9.92
 
Forfeited
    (37,456
)
 
$
8.5  
Unvested as of December 31, 2021
   
3,910,601
   
$
8.87
 
Summary of Management earn-out shares

 

   
May 12, 2021
 
       
Share Price
 
 
$9.75  
Expected volatility
    77.50%
 
Risk-Free interest rate
    0.66%
 
Threshold
 
 
$12.5  
Term (years)
   
4
 
Summary of Share-Based Payment Arrangement, Expensed and Capitalized, Amount
   
Year ended December 31,
 
   
2021
   
2020
   
2019
 
                   
Research and development
 
$
25,504    
$
2,649    
$
1,695  
Sales and marketing
    17,153       338       374  
General and administrative
    22,079       209       102  
 
                       
   
$
64,736    
$
3,196    
$
2,171